[1] BURZYKOWSKI T, MOLENBERGHS G, ABECK D, et al. High prevalence of foot diseases in Europe:results of the Achilles Project[J]. Mycoses. 2003,46(11-12):496-505.
[2] ILKIT M, DURDU M. Tinea pedis:the etiology and global epidemiology of a common fungal infection[J].Crit Rev Microbiol. 2015;41(3):374-388.
[3] MAHREEN AMEEN. Epidemiology of superficial fungal infections[J]. Clinics in Dermatology. 2010,28(2):197-201.
[4] HAVLICKOVA B, CZAIKA V A, FRIEDRICH M. Epidemiological trends in skin mycoses worldwide[J]. Mycoses. 2008,51(Suppl 4):2-15.
[5] 杨利红,赵颖,严淑贤,等.上海新泾社区50岁以上居民足癣患病情况调查[J].中国真菌学杂志,2012,7(2):92-94.
[6] WATANABE S1, HARADA T, HIRUMA M, et al. Epidemiological survey of foot diseases in Japan:results of 30,000 foot checks by dermatologists[J]. J Dermatol. 2010 May;37(5):397-406.
[7] CHENG S, CHONG L. A prospective epidemiological study on tinea pedis and onychomycosis in Hong Kong[J]. Chin Med J (Engl). 2002 Jun;115(6):860-865.
[8] 费实,肖常青,李振洁,等.1999~2007年皮肤科门诊浅部真菌发病及镜检情况分析[J]. 中国真菌学杂志,2009,4(2):93-96,101.
[9] 王爱平,高露娟,席丽艳,等.手足癣治疗现状[J].中国真菌学杂志, 2014, 9(6):335-338.
[10] WILSON M, BENDER S, LYNFIELD Y, et al. Two feet-one hand syndrome[J]. J Am Podiatr Med Assoc.1988, 78(5):250-253.
[11] ZHAN P, GE Y P, LU X L, et al. A case-control analysis and laboratory study of the two feet-one hand syndrome in two dermatology hospitals in China[J]. Clin Exp Dermal. 2010,35(5):468-472.
[12] 徐楠,温海.足癣复发对患者生活质量的影响[J]. 中国真菌学杂志,2006,l(3):174-176
[13] 李春阳,李诚菊,徐永豪,等. 2%酮康唑乳膏治疗浅部真菌病开放性、随机对照临床研究[J]. 中国真菌学杂志, 2011,6(2):112-114
[14] 王爱平,温海,赖维,等. 1%联苯苄唑霜治疗足癣长期疗效观察[J]. 中国真菌学杂志, 2008,3(4):224-227.
[15] 符美华,李岷,李若瑜,等.不同疗程1%卢立康唑乳膏治疗足癣的多中心、随机双盲对照研究[J].中华皮肤科杂志,2014,47(7):453-456.
[16] JARRATT M, JONES T, ADELGLASS J, et al. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥ 12 years of age with interdigital tinea pedis:a phase 3, randomized, double-blind,vehicle-controlled study[J]. J Drugs Dermatol. 2014 Jul;13(7):838-846.
[17] KORTING H C, KIENCKE P, NELLES S, et al. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen:results of a meta-analysis[J]. Am J Clin Dermatol. 2007;8(6):357-364.
[18] JAMES I G, LORIA-KANZA Y, JONES T C. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel:results of a dose-ranging clinical trial[J]. J Dermatolog Treat. 2007,18(3):163-168.
[19] LI R Y, WANG A P, XU J H,et al. Efficacy and safety of 1% terbinafine film-forming solution in Chinese patients with tinea pedis:a randomized, double-blind, placebo-controlled, multicenter, parallel-group study[J]. Clin Drug Investig. 2014,34(3):223-230.
[20] 李岷,顾军,毕志刚,等.1%盐酸布替萘芬乳膏治疗体股癣、足癣疗效观察[J].临床皮肤科杂志,2006, 35(7):471-472.
[21] GUPTA A K. Butenafine:an update of its use in superficial mycoses[J]. Skin Therapy Lett. 2002,7(7):1-2, 5.
[22] STEIN GOLD L F, PARISH L C, VLAHOVIC T, et L. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis:pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials[J]. J Drugs Dermatol. 2013,12(8):911-918.
[23] 王爱平,余进,陈伟,等. 0.25%盐酸阿莫罗芬霜治疗足癣疗效和安全性评价[J].中国真菌学杂志,2007,2 (5):293-295.
[24] 王爱平,王端礼,虞瑞尧,等.1%环吡酮胺软膏治疗皮肤真菌病疗效观察[J].中华皮肤科杂志, 1998,31 (5):337
[25] ALY R, FISHER G, KATZ I, et al. Ciclopirox gel in the treatment of patients with interdigital tinea pedis[J]. Int J Dermatol. 2003, 42 Suppl 1:29-35.
[26] 王英,沈永年,朱红梅,等.利拉萘酯乳膏治疗体股癣及足癣的多中心随机双肓对照观察[J]. 中华皮肤科杂志,2007,40(8):476-478.
[27] GUPTA A K, FOLEY K A, Versteeg S G. New Antifungal Agents and New Formulations Against Dermatophytes[J]. Mycopathologia. 2017,182(1-2):127-141.
[28] Tsunemi Y1. Oral Antifungal Drugs in the Treatment of Dermatomycosis[J]. Med Mycol J. 2016,57(2):J71-75. |
